Canada markets closed

BioNexus Gene Lab Corp. (BGLC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.6144+0.0134 (+2.23%)
At close: 04:00PM EDT
0.6071 -0.01 (-1.19%)
After hours: 04:26PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 10.95M
Enterprise Value 5.16M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.01
Price/Book (mrq)1.13
Enterprise Value/Revenue 0.53
Enterprise Value/EBITDA -2.07

Trading Information

Stock Price History

Beta (5Y Monthly) 1.95
52-Week Change 389.02%
S&P500 52-Week Change 323.57%
52 Week High 39.4900
52 Week Low 30.0800
50-Day Moving Average 30.6966
200-Day Moving Average 30.8771

Share Statistics

Avg Vol (3 month) 31.6M
Avg Vol (10 day) 3472.23k
Shares Outstanding 517.67M
Implied Shares Outstanding 617.67M
Float 89.96M
% Held by Insiders 164.38%
% Held by Institutions 10.59%
Shares Short (Apr 15, 2024) 499.74k
Short Ratio (Apr 15, 2024) 41.15
Short % of Float (Apr 15, 2024) 40.58%
Short % of Shares Outstanding (Apr 15, 2024) 40.56%
Shares Short (prior month Mar 15, 2024) 420.06k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -26.91%
Operating Margin (ttm)7.36%

Management Effectiveness

Return on Assets (ttm)-12.68%
Return on Equity (ttm)-32.21%

Income Statement

Revenue (ttm)9.77M
Revenue Per Share (ttm)0.62
Quarterly Revenue Growth (yoy)-20.00%
Gross Profit (ttm)N/A
EBITDA -1.96M
Net Income Avi to Common (ttm)-2.63M
Diluted EPS (ttm)-0.1800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.93M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)146.59k
Total Debt/Equity (mrq)1.52%
Current Ratio (mrq)4.93
Book Value Per Share (mrq)0.55

Cash Flow Statement

Operating Cash Flow (ttm)-1.3M
Levered Free Cash Flow (ttm)566.75k